The Inside Scoop: A Peek at Recent Insider Trades in Four Promising Stocks

Avatar photo



Closing higher on Thursday, U.S. stocks showed positive signs amidst notable insider trades.


When insiders buy shares, it reflects confidence or belief in undervaluation. An opportunity may be brewing. However, insider trades should not dictate investment decisions alone – at best, they offer insight.


Keep an eye on these recent insider moves. For more, visit Benzinga’s insider transactions platform.


Insider Scoop: Beyond, Inc.


  • The Trade: Beyond, Inc. BYON Executive Chairman Marcus Lemonis accumulated 3,650 shares averaging $27.17 each, totaling around $99,171.
  • What’s Happening: Beyond reported a wider-than-expected Q4 loss on Feb. 20.
  • Company Profile: Beyond Inc is an online retailer offering a wide range of products – from furniture to electronics.


Insider Scoop: West Bancorporation


  • The Trade: West Bancorporation, Inc. WTBA CEO and President David D Nelson acquired 2,007 shares at an average price of $17.55, totaling around $35,223.
  • What’s Happening: West Bancorp posted disappointing quarterly results on Jan. 25.
  • Company Profile: West Bancorp Inc offers a range of deposit services.


Don’t miss our premarket coverage here.


Insider Scoop: Hudson Pacific Properties


  • The Trade: Hudson Pacific Properties, Inc. HPP Director Barry A Sholem purchased 80,000 shares at an average price of $6.69, totaling around $535,200.
  • What’s Happening: Hudson Pacific Properties reported below-par Q4 financials on Feb. 12.
  • Company Profile: Hudson Pacific Properties Inc is a real estate investment trust with a focus on properties along America’s West Coast.


Insider Scoop: Exelixis


  • The Trade: Exelixis, Inc. EXEL Director Caligan Partners LP Johnson purchased 190,000 shares averaging $20.70 each, totaling about $3.93 million.
  • What’s Happening: Exelixis posted positive quarterly earnings on Feb. 6.
  • Company Profile: Exelixis focuses on discovering, developing, and commercializing cancer treatments.



For more insights, explore Investor Optimism Improves Further; S&P 500 Settles At Record High





The free Daily Market Overview 250k traders and investors are reading

Read Now